Latest Articles
![]() Insomnia and Short Sleep Duration Associated With Increased Mortality RiskAccording to research, men with insomnia and sleep duration of six or fewer hours... |
![]() Walnut Consumption Significantly Decreases LDL CholesterolResearchers have found that high-walnut-enriched diets significantly decreased total and LDL cholesterol for the... |
![]() Dietary Fat Linked to Pancreatic CancerAccording to a study, high intake of dietary fats from red meat and dairy... |
![]() New Evidence Why Repair of Myelin Fails in Multiple SclerosisResearch has uncovered new evidence suggesting that damage to nerve cells in people with... |
![]() Memory Test Helps Understand Parkinson's Disease Effect on BehaviorA new neuropsychological memory test developed by Dr. Mark Gluck, is helping to uncover... |
![]() Patient Receives Cardiac Stem Cells in Clinical TrialDoctors at the Cedars-Sinai Heart Institute have announced the completion of the first procedure... |
![]() Mechanism for Amyloid Beta Protein's Toxic Impact in Alzheimer'sResearchers have uncovered a novel mechanism linking soluble amyloid β protein with the synaptic... |
Most Read
![]() What You Eat May Reduce or Increase Your Risk of Alzheimer’sFrequent consumption of fruits and vegetables, fish and omega-3 rich oils may decrease the... |
![]() 3-D Images of Eyes Developed to Reveal Details of Macular DegenerationTo get a better look at the abnormalities that cause age-related macular degeneration, the... |
![]() Omega-3 Fatty Acids Reduce Risk of Advanced Prostate CancerAccording to a study by John S. Witte and colleagues, omega-3 fatty acids appear... |
![]() Vibration Plate Machines Could Aid Weight Loss and Shed Belly FatAccording to research, with proper use, vibration plate exercise machines could trim the particularly... |
![]() Cherry Supplement Improves Pain and Function in OsteoarthritisAccording to recent research, ground whole Montmorency tart cherries in pill form may be... |
![]() Psoriasis Associated With Cardiovascular DiseaseAccording to research, the skin disease psoriasis is associated with atherosclerosis (a buildup of... |
![]() Green Tea Component Has Potential To Inhibit HIV InfectionA chemical that occurs naturally in green tea appears to prevent HIV-1 (the virus... |
| Treating and Preventing Alzheimer's Naturally |
|
Alzheimer’s is a progressive disorder that is characterized by the decline in intellectual abilities, eventually leading to dementia in elderly patients. The cause it not known, although it has been estimated 40% of people over 85 years old suffer from this condition. Closer examination of the brains of people who have died from Alzheimer’s has shown a loss of cells that release a chemical called acetylcholine – the cells that are used for thinking. The first signs of Alzheimer’s are loss of short-term memory for names and recent events. This then progresses to a difficulty learning new information, possibly eccentric behavior, depression and loss of spontaneity. As Alzheimer’s continues to affect the sufferer, they will lose the ability to carry out everyday activities, questions will be asked repeatedly, and they may lose the ability to recognize friends and family. Eventually nearly all mental functions will fail, a similar symptom to those suffering from multiple small strokes and severe alcoholism. Natural Remedies for Alzheimer's.
References:
1. Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging (Milano). 1993 Apr;5(2):123-33. PMID: 8323999. 2. Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, Ylieff M. Double-blind randomized controlled study of phosphatidylserine in senile demented patients. Acta Neurol Scand. 1986 Feb;73(2):136-40. PMID: 3518329. 3. Engel RR, Satzger W, Günther W, Kathmann N, Bove D, Gerke S, Münch U, Hippius H. Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type. Eur Neuropsychopharmacol. 1992 Jun;2(2):149-55. PMID: 1633433. 4. Napryeyenko O, Borzenko I; GINDEM-NP Study Group. Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial. Arzneimittelforschung. 2007;57(1):4-11. PMID: 17341003. 5. Mazza M, Capuano A, Bria P, Mazza S. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Eur J Neurol. 2006 Sep;13(9):981-5. PMID: 16930364. 6. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA. 1997 Oct 22-29;278(16):1327-32. PMID: 9343463. 7. Scripnikov A, Khomenko A, Napryeyenko O; GINDEM-NP Study Group. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial. Wien Med Wochenschr. 2007;157(13-14):295-300. PMID: 17704975. 8. Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol. 2003 Mar;18(2):61-71. PMID: 12598816. 9. Carta A, Calvani M. Acetyl-L-carnitine: a drug able to slow the progress of Alzheimer's disease? Ann N Y Acad Sci. 1991;640:228-32. PMID: 1776743. 10. Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol Psychiatry. 2000 Nov;5(6):616-32. PMID: 11126392. 11. Brooks JO 3rd, Yesavage JA, Carta A, Bravi D. Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach. Int Psychogeriatr. 1998 Jun;10(2):193-203. PMID: 9677506. 12. Thal LJ, Carta A, Clarke WR, Ferris SH, Friedland RP, Petersen RC, Pettegrew JW, Pfeiffer E, Raskind MA, Sano M, Tuszynski MH, Woolson RF. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology. 1996 Sep;47(3):705-11. PMID: 8797468. 13. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther. 2003 Feb;28(1):53-9. PMID: 12605619. 14. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):863-6. PMID: 12810768. 15. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):863-6. PMID: 12810768. 16. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997 Apr 24;336(17):1216-22. PMID: 9110909. 17. De Jesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clin Ther. 2003 Jan;25(1):178-93. PMID: 12637119. 18. Xu SS, Gao ZX, Weng Z, Du ZM, Xu WA, Yang JS, Zhang ML, Tong ZH, Fang YS, Chai XS. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. Zhongguo Yao Li Xue Bao. 1995 Sep;16(5):391-5. PMID: 8701750. 19. Hindmarch I, Fuchs HH, Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol. 1991 Spring;6(1):31-43. PMID: 2071888. 20. Ziv N, Granot A, Hai S, Dassa A, Haimov I. The effect of background stimulative music on behavior in Alzheimer's patients. J Music Ther. 2007 Winter;44(4):329-43. PMID: 17997624. 21. Bannan N, Montgomery-Smith C. 'Singing for the brain': reflections on the human capacity for music arising from a pilot study of group singing with Alzheimer's patients. J R Soc Health. 2008 Mar;128(2):73-8. PMID: 18402177. 22. Holmes C, Knights A, Dean C, Hodkinson S, Hopkins V. Keep music live: music and the alleviation of apathy in dementia subjects. Int Psychogeriatr. 2006 Dec;18(4):623-30. PMID: 16805928. 23. Clark ME, Lipe AW, Bilbrey M. Use of music to decrease aggressive behaviors in people with dementia. J Gerontol Nurs. 1998 Jul;24(7):10-7. PMID: 9801526. 24. Image by gregR. Related Articles
|




















